6 Reference

  1. Ferlay J, Soerjomataram I, Dikshit R et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer 2015; 136: 359–386.
  2. Morton LM, Slager SL, Cerhan JR et al. Etiologic Heterogeneity Among Non-Hodgkin Lymphoma Subtypes: The InterLymph Non-Hodgkin Lymphoma Subtypes Project. Journal of the National Cancer Institute Monographs 2014; 48: 130-144.
  3. Huh J. Epidemiologic overview of malignant lymphoma. The Korean Journal of Hematology. 2012; 47(2): 92-104.
  4. Roman E and Smith AG. Epidemiology of lymphomas. Histopathology 2011; 58: 4–14.
  5. Oerlemans S, Mols F, Issa DE et al. A high level of fatigue among long-term survivors of non-Hodgkin’s lymphoma: results from the longitudinal population-based PROFILES registry in the south of the Netherlands. Haematologica 2013; 98(3): 479-486.
  6. Jensen RE, Arora NK, Belizzi KM et al. Health-related quality of life among survivors of aggressive non-Hodgkinlymphoma. Cancer 2013; 119(3): 672–680.
  7. Blaes AH, Ma L, Zhang Y et al. Quality of life appears similar between survivors of indolent and aggressive non-Hodgkin lymphoma. Leuk Lymphoma 2011; 52(11): 2105–2110.
  8. Bower JE. Cancer-related fatigue: Mechanisms, risk factors, and treatments. Nature reviews Clinical oncology 2014; 11(10): 597-609.
  9. Berger AM, Mooney K, Alvarez-Perez A et al. Cancer-Related Fatigue, Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : JNCCN. 2015; 13(8): 1012-1039.
  10. Boyle T, Connors JM, Gascoyne R et al. Physical activity, obesity and survival in diffuse large B-cell and follicular lymphoma cases. British Journal of Haematology 2017; 178: 442-447.
  11. Kohler LN, Garcia DO, Harris RB et al. Adherence to Diet and Physical Activity Cancer Prevention Guidelines and Cancer Outcomes: A Systematic Review. Cancer Epidemiol Biomarkers Prev.2016; 25(7): 1018-28.
  12. Friedenreich CM and Orenstein MR. Physical activity and cancer prevention: etiologic evidence and biological mechanisms. J. Nutr.2002; 132: 3456–3464.
  13. Anand P, Kunnumakara AB, Sundaram C, et al. Cancer is a Preventable Disease that Requires Major Lifestyle Changes. Pharmaceutical Research 2008; 25(9): 2097-2116.
  14. Spence RR, Heesch KC, Brown WJ et al. A systematic review of the association between physical activity and colorectal cancer risk. Scand. J. Med. Sci. Sports 2009; 19: 764–781.
  15. Kelly SA, Zhao L, Jung KCH et al. Prevention of tumorigenesis in mice by exercise is dependent on strain background and timing relative to carcinogen exposure. Scientific Reports 2017; 7: 43086.
  16. Pedersen L, Idorn M, Olofsson GH et al. Voluntary Running Suppresses Tumor Growth through Epinephrine- and IL-6-Dependent NK Cell Mobilization and Redistribution. Cell Metabolism 2016; 23(3): 554 – 562.
  17. Bergström A, Terry P, Lindblad P et al. Physical activity and risk of renal cell cancer. Int J Cancer 2001; 92(1): 155-7.
  18. Michaud DS, Giovannucci E, Willet WC et al. Physical activity, obesity, height, and the risk of pancreatic cancer. JAMA 2001; 286(8): 921-9.
  19. Wen CP, Wai JP, Tsai MK et al. Minimum amount of physical activity for reduced mortality and extended life expectancy: a prospective cohort study. Lancet 2011; 378: 1244–1253.
  20. Brown, JC, Winters-Stone K, Lee A et al. Cancer, physical activity, and exercise. Comprehensive Physiology 2012; 2: 2775–2809.
  21. Bade BC, Thomas DD, Scott JB et al. Increasing physical activity and exercise in lung cancer: reviewing safety, benefits, and application. J Thorac Oncol 2015; 10(6): 861-71.
  22. Holmes MD, Chen WY, Feskanich D et al. Physical activity and survival after breast cancer diagnosis. JAMA 2005; 293: 2479–2486.
  23. Máček M, Radvanský J. Fyziologie a klinické aspekty pohybové aktivity. Praha: Galén, c2011. ISBN 9788072626953.
  24. Steffen TM, Hacker TA, Mollinger L et al. Age- and gender-related test performance in community-dwelling elderly people: Six-Minute Walk Test, Berg Balance Scale, Timed Up & Go Test, and gait speeds. Phys Ther 2002; 82(2): 128-37.
  25. Ries JD, Echternach JL, Nof L et al. Test-Retest Reliability and Minimal Detectable Change Scores for the Timed “Up & Go” Test, the Six-Minute Walk Test, and Gait Speed in People With Alzheimer Disease. Physical Therapy 2009; 89(6): 569–579.
  26. Achten J, Jeukendrup AE, Asker E et al. Heart rate monitoring: applications and limitations. Sports Med 2003; 33(7): 517-38.
  27. Da Cunha FA, Farinatti Pde T, Midglay AW et al. Methodological and practical application issues in exercise prescription using the heart rate reserve and oxygen uptake reserve methods. Sci Med Sport 2011; 14(1): 46-57.
  28. Hampton S, Armstrong G, Shah MV et al. Quantification of perceived exertion during isometric force production using Borg scale in healthy individuals and in chronic stroke patients. Topics in stroke rehabilitation 2014; 21(1): 33-39.
  29. Aagaard P, Andersen JL, Bennekou M, et al. Effects of resistance training on endurance capacity and muscle fiber composition in young top-level cyclists. Scandinavian Journal of Medicine & Science in Sports 2011; 21: 298–307.
  30. Lehnert M, Novosad J, Neuls F et al. Trénink kondice ve sportu. Olomouc: Univerzita Palackého v Olomouci, 2010. ISBN 978-80-244-2614-3
  31. Wind AE, Takken T, Helders PJ et al. Is grip strength a predictor for total muscle strength in healthy children, adolescents, and young adults? Eur J Pediatr 2010; 169 (3): 281–7.
  32. Velghe A, De Buyser, Noens L et al. Hand grip strength as a screening tool for frailty in older patients with haematological malignancies. Acta Clinica Belgica 2016; 71(4): 227-30.
  33. Granger CL, McDonald CF, Parry SM et al. Functional capacity, physical activity and muscle strength assessment of individuals with non-small cell lung cancer: a systematic review of instruments and their measurement properties. BMC Cancer 2013; 13:135-140.
  34. Tieland M, Verdiik LB, de Groot LC et al. Handgrip Strength Does Not Represent an Appropriate Measure to Evaluate Changes in Muscle Strength during an Exercise Intervention Program in Frail Older People. International Journal of Sport Nutrition and Exercise Metabolism 2015; 25(1): 27-36.
  35. Podsiadlo D and Richardson S. ´The timed 'Up & Go': A test of basic functional mobility for frail elderly persons". Journal of the American Geriatrics Society 1991; 39(2): 142–8.
  36. Nyberg LA, Hellénius M, Wandell P et al. Maximal step-up height as a simple and relevant health indicator: a study of leg muscle strength and the associations to age, anthropometric variables, aerobic fitness and physical function. Br J Sports Med 2013; 47: 992-997.
  37. Bohannon RW, Richard W, Magasi SR et al. “Sit-to-Stand Test: Performance and Determinants across the Age-Span.” Isokinetics and exercise science 2010; 18(4): 235–240.
  38. Jones AM, Vanhatalo A, Burnley M et al. Critical power: implications for determination of V˙O2max and exercise tolerance. Med Sci Sports Exerc. 2010 O; 42(10):1876-90.
  39. Duren DL, Sherwood RJ, Czerwinski SA et al. Body composition methods: comparisons and interpretation. J Diabetes Sci Technol. 2008; 2(6):1139-46.
  40. Hottenrott K, Hoos O and Esperer HD. Heart rate variability and physical exercise – current status. Herz 2006; 31(6): 544-52.
  41. Kop WJ, Stein PK, Tracy RP et al. Autonomic Nervous System Dysfunction and Inflammation Contribute to the Increased Cardiovascular Mortality Risk Associated With Depression. Psychosomatic medicine 2010; 72(7): 626-635.
  42. Indumathy J, Pal GK, Pal P et al. Association of sympathovagal imbalance with obesity indices, and abnormal metabolic biomarkers and cardiovascular parameters. Obesity Research & Clinical Practice 2015; 9(1): 55-66.
  43. Giese-Davis J, Wilhelm FH, Tamagawa R et al. Higher vagal activity as related to survival in patients with advanced breast cancer: an analysis of autonomic dysregulation. Psychosom Med. 2015; 77(4): 346-55
  44. Guo Y, Koshy S, Hui Det al. Prognostic Value of Heart Rate Variability in Patients with Cancer. Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society. 2015;32(6):516-520.
  45. Fadul N, Strasser F, Palmer JL et al. The association between autonomic dysfunction and survival in male patients with advanced cancer: a preliminary report. J Pain Symptom Manage 2010; 39: 283–290.
  46. Stejskal P, Šlachta R, Elfmark M et al. Spectral analysis of heart rate variability: new evaluation method. Acta Univ Palacky Olomuc 2002; 32(2): 13-18.
  47. Galuszka J, Stejskal P, Lukl J et al. Assessment of spectral analysis of heart rate variability in patients with history of atrial fibrillation by means of age-dependent parameters. Biomed Papers 2002; 146(2): 81-85.
  48. Niederer D, Vogt L, Thiel C et al. Exercise effects on HRV in cancer patients. Int J Sports Med. 2013; 34(1): 68-73
  49. Franco MR, Tong A, Howard K et al. Older people's perspectives on participation in physical activity: a systematic review and thematic synthesis of qualitative literature. Br J Sports Med. 2015; 49(19): 1268-76.
  50. Lee I-M, Shiroma EJ, Lobelo F et al. Impact of Physical Inactivity on the World’s Major Non-Communicable Diseases. Lancet 2012; 380(9838): 219-229.
  51. Gerovasili V, Agaku IT, Filippidis FE et al. Levels of physical activity among adults 18-64 years old in 28 European countries. Prev Med. 2015; 81: 87-91.
  52. Marques A, Sarmento H, Martins J et al. Prevalence of physical activity in European adults – Compliance with the World Health Organization's physical activity guidelines. Prev Med 2015; 81: 333-8.
  53. Hallal CP, Andersen LB, Bull FC et al. Global physical activity levels: surveillance progress, pitfalls, and prospects. Lancet 2012; 380 (9838): 247-257.
  54. Janíková A., Radvanský J, Vysoký R et al. Význam fyzické aktivity u pacientů s hematoonkologickými malignitami. Transfuze a hematologie dnes 2012; 18: 31-38.
  55. Kampshoff CS, van Mechelen W, Schep G, et al. Participation in and adherence to physical exercise after completion of primary cancer treatment. The International Journal of Behavioral Nutrition and Physical Activity. 2016; 13(1):100.
  56. Bilora F, Veronese F, Zancan A et al. Autonomic dysfunction in Hodgkin and non-Hodgkin lymphoma. A paraneoplastic syndrome? Hematol Rep 2010; 2(1): e8
  57. De Couck M, van Brummelen D, Schallier D et al. The relationship between vagal nerve aktivity and clinical outcomes in prostate and non-small cell lung cancer patients. Oncol Rep 2013; 30(5): 2435-41.
  58. Vermaete N, Wolter P, Verhoef G et al. Physical activity and physical fitness in lymphoma patients before, during, and after chemotherapy: a prospective longitudinal study. Ann Hematol 2014; 93: 411-424.
  59. Götte M, Kesting S, Winter C et al. Comparison of self-reported physical activity in children and adolescents before and during cancer treatment. Pediatr Blood Cancer 2014; 61(6): 1023-8.
  60. Cunningham D, Hawkes EA, Jack A et al. Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles. Lancet 2013; 381(9880): 1817 – 1826.
  61. Eichenauer DA, Engert A, André M et al. on behalf of the ESMO Guidelines Working GroupHodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Annals of Oncology 2014; 25(3): 70-77.
  62. Inder WJ, Jang C, Obeyesekere VR et al. Dexamethasone administration inhibits skeletal muscle expression of the androgen receptor and IGF-1--implications for steroid-induced myopathy 2010; 73(1): 126-32.
  63. Minetto MA, Qaisar R, Agoni V et al. Quantitative and qualitative adaptations of muscle fibers to glucocorticoids. Muscle Nerve 2015; 16: 631-639.
  64. Danon MJ and Schliselfeld LH. Study of skeletal muscle glycogenolysis and glycolysis in chronic steroid myopathy, non-steroid histochemical type-2 fiber atrophy, and denervation. Clin Biochem 2007; 40(1-2): 46-51.
  65. Straus DJ. Long-Term Survivorship at a Price: Late-Term, Therapy-Associated Toxicities in the Adult Hodgkin Lymphoma Patient. Therapeutic Advances in Hematology 2011; 2(2): 111-119.
  66. Caruso V, Di Castelnuovo A, Meschengieser S et al. Thrombotic complications in adult patients with lymphoma: a meta-analysis of 29 independent cohorts including 18 018 patients and 1149 events. Blood 2010; 115(26): 5322-5328.
  67. Banach M, Juranek JK, Zygulska AL et al. Chemotherapy‐induced neuropathies — a growing problem for patients and health care providers. Brain and Behavior 2017; 7(1): e00558.
  68. Kerckhove N, Collin A, Condé S et al. Long-Term Effects, Pathophysiological Mechanisms, and Risk Factors of Chemotherapy-Induced Peripheral Neuropathies: A Comprehensive Literature Review. Frontiers in Pharmacology 2017; 8: 86.
  69. Nousiainen T, Vanninen E, Jantunen E et al. Neuroendocrine changes during evolution of doxorubicin-induced left ventricular dysfunction in adult lymphoma patients. Clin Sci 2001; 101(6): 601-7.
  70. Simunek T, Sterba M, Popelova A et al. Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron. Pharmacol Rep. 2009; 61(1): 154-71.
  71. Mège A, Ziouèche A, Porel N et al. Toxicité cardiaque de la radiothérapie. Cancer/Radiothérapie, 2010; 15(6), 495-503.
  72. Elter T, Stipanov M, Heuser E et al. Is physical exercise possible in patients with critical cytopenia undergoing intensive chemotherapy for acute leukaemia or aggressive lymphoma? Int J Hematol. 2009; 90(2): 199-204.
  73. Dimeo F, Fetscher S, Lange W et al. Effects of Aerobic Exercise on the Physical Performance and Incidence of Treatment-Related Complications After High-Dose Chemotherapy. Blood 1997; 90(9): 3390-3394.
  74. Bergenthal N, Will A, Streckmann F et al. Aerobic physical exercise for adult patients with haematological malignancies. Cochrane Database of Systematic Reviews 2014; 11.
  75. Ishikawa A and Tsuji T. The impact of rehabilitation on patients undergoing hematopoietic stem cell transplantation, Journal of Hematopoietic Cell Transplantation 2016; 4 (5): 107-117.
  76. Tarnowski M, Piotrowska K, Grymula K et.al. Prolonged Strenuous Exercise Expands the Population of Developmentally Early Stem Cells in Bone Marrow (BM) and Mobilizes Them Into Peripheral Blood – Novel Evidence That Strongly Supports a Positive Effect of Physical Activity On Extension of Life Span At the Level of Stem Cells. Blood 2012; 120(21) 584.
  77. http://ec.europa.eu/assets/eac/sport/library/policy_documents/eu-physical-activity-guidelines-2008_en.pdf
  78. http://www.fsps.muni.cz/spa/vysledky/
  79. McNeely ML, Campbell KL, Rowe BH et al. Effects of exercise on breast cancer patients and survivors: A systematic review and meta-analysis. Can Med Assoc J. 2006; 175: 34–41.
  80. Meyerhardt JA, Giovanucci EL, Holmes MD et al. Physical activity and survival after colorectal cancer diagnosis. J Clin Oncol 2006; 24: 3527–3534.
  81. Bellizzi KM, Rowland JH, Jeffery DD et al. Physical Activity and Quality of Life in Adult Survivors of Non-Hodgkin’s Lymphoma. Journal of Clinical Oncology. 2009; 27(6): 960-966.
Předcházející kapitolaPředcházející kapitola
Seznam kapitol Seznam kapitol